Diabeloop is a French company developing a disruptive technological innovation to automate the treatment of type one diabetes.
Lift the daily burden caused by the disease and allow patients to finally live the life they want!
Diabeloop has over 30 employees. CE marking, necessary to go to market, is in progress.
A Smart therapeutic assistant that automates Type 1 diabetes treatment.
The DBLG1 system is an external medical device closing the loop between a continuous glucose monitor (CGM) and a patch insulin pump.
Our R&D team has been working on the artificial intelligence that brings to life this cutting-edge innovation. The solution is based on complex algorithms that predict future blood sugar level and automates insulin delivery.
Data are sent to a secured server and readily available for the patient and the persons of their choice.
Adjustable parameters that fit the user's physiology.
2h blood glucose forecasting
Basal insulin self-adjustement / stop
Predictive alerts before hypoglycaemia.
Recommendations for treatment optimisation based on collected data.
One device to monitor insulin delivery, blood glucose and system proper functioning.